Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy-Reference-Cited by-同舟云学术

Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy

Published:2022-07-18 Issue:5 Volume:9 Page:3435-3451
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Fujita Yugo¹,Yano Toshiyuki¹,Kanamori Hiromitsu²,Nagahara Daigo¹,Muranaka Atsuko¹,Kouzu Hidemichi¹,Mochizuki Atsushi¹,Koyama Masayuki¹³,Nagano Nobutaka¹,Fujito Takefumi¹,Nishikawa Ryo¹,Kamiyama Naoyuki¹,Tanaka Marenao¹,Kuno Atsushi¹⁴,Tanno Masaya¹,Miura Tetsuji¹⁵^ORCID

Affiliation:

1. Department of Cardiovascular, Renal and Metabolic Medicine Sapporo Medical University School of Medicine Sapporo 060‐8543 Japan

2. Department of Cardiology Gifu University Graduate School of Medicine Gifu Japan

3. Department of Public Health Sapporo Medical University School of Medicine Sapporo Japan

4. Department of Pharmacology Sapporo Medical University School of Medicine Sapporo Japan

5. Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences Hokkaido University of Science Sapporo Japan

Funder

NOVARTIS Foundation (Japan) for the Promotion of Science

Takeda Science Foundation

Uehara Memorial Foundation

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14059

Reference54 articles.

1. Dilated Cardiomyopathy

2. Dilated cardiomyopathy

3. Improved Long-Term Prognosis of Dilated Cardiomyopathy With Implementation of Evidenced-Based Medication　– Report From the CHART Studies –

4. Dilated cardiomyopathy

5. Initiation and execution mechanisms of necroptosis: an overview

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of MLKL to the development of doxorubicin-induced cardiomyopathy and its amelioration by rapamycin;Journal of Pharmacological Sciences;2024-09

2. Luteolin-7-O-β-d-glucuronide Ameliorates Cerebral Ischemic Injury: Involvement of RIP3/MLKL Signaling Pathway;Molecules;2024-04-07

3. A year in heart failure: updates of clinical and preclinical findings;ESC Heart Failure;2023-04-18

4. Regulated cell death pathways in cardiomyopathy;Acta Pharmacologica Sinica;2023-03-13

5. Nuclear translocation of MLKL enhances necroptosis by a RIP1/RIP3-independent mechanism in H9c2 cardiomyoblasts;J PHARMACOL SCI;2023